The Effectiveness of RNA Interference at Inhibiting the Proliferation of HSV-1 by Silencing ICP27
CSEF · 2004 Biochemistry/ Molecular Biology
Overview
Objectives/Goals Determine what sequence of siRNA is most effective in targeting ICP27. Compare the amount of viral proteins between cells with and without RNAi. Determine whether RNAi can inhibit HSV-1 infection. Methods/Materials 1) Synthesize siRNA corresponding to desired genomic sequence of ICP27 of Herpes Simplex Virus Type 1 (HSV-1). 2) Determine which strands of siRNA are most effective via gel electrophoresis (SDS PAGE). 3) Transfect HeLa cells with siRNA and Oligofectamine Reagent. 4) Infect HeLa cells with HSV-1, harvest after 5-6 hrs. 5) Collect samples and run SDS PAGE; continue with a Western Blot. 6) Proceed with antibody staining and develop onto film. 7) For HSV-1 infected cells, label in vivo with S35-methionine to measure protein production and run SDS PAGE. 8) Stain gel with Coomassie blue for visualization. 9) Collect infected cells for a plaque assay count. Results Results confirm that siRNA is extremely effective in knocking down ICP27, with knockdowns upwards of 84% and statistical significance at the P=0.00446 level. Differences among siRNA sequences were not statistically significant (P=0.2112). The silencing of ICP27 shown by Western blots resulted only in minor differences in the amount of viral proteins between normal cells infected by HSV-1 and those with siRNA, shown by autoradiography and Coomassie blue staining. The plaque assays show siRNA#2 is more effective than siRNA#3 in inhibiting the proliferation of HSV-1. The number of plaque forming units (pfu) shows that HSV-1 cannot reproduce without ICP27. The difference in number of pfu in the mock and siRNA wells is statistically significant at the P=0.08987 level. A comparison of the siRNA wells shows that siRNA#2 worked better than siRNA#3 at bringing down the infection rate, statistically significant at the a=0.05 level with a p-value of 0.023. Conclusions/Discussion Our hypothesis was partially correct. Reduction of the viral protein ICP27 was successful, but a complete knockdown may be necessary to stop the proliferation of the virus. Further research includes using multiple siRNAs simultaneously or targeting several important proteins at once. Our research serves as a
Summary statement
In this study, RNAi is used to silence ICP27, a crucial protein that exports intronless viral mRNA in Herpes Simplex Virus (HSV-1), in hopes of inhibiting the proliferation of HSV-1 in HeLa cell culture.
Help received
Used lab equipment at the University of California, Irvine under the supervision of Dr. Rozanne Sandri-Golden and Santos Rojas; Santos Rojas did infections for us.
Awards (1)
- Category Award
Competition history
- CSEF 2004
Resources
Related projects
CSEF · 2009
Using RNA Interference to Block HIV Entry into Cells
CSEF · 2017
Combating Embryonic Neurovirulence of Zika and Flaviviruses Using InSilico Phylogenetic Analysis and RNAi Gene Silencing
CSEF · 2015
Gentamicin Assay: A Study of the Effects of Gene Suppression on E. coli Infectivity Rates
CSEF · 2014
A Novel Reporter System for Analyzing and Evaluating a Smart Bomb Approach to Annihilate HIV
CSEF · 2002
The Effect of Directing Ribozymes to Attack Proliferating Cell Nuclear Antigens and Inhibit the Growth of Cancer Cells
ISEF · 2016
Effect of Transitive RNAi on Gene Expression in Human Cells
CSEF · 2006
Preliminary siRNA Analysis of Genes Implicated in Neuronal Differentiation and Neurite Outgrowth
ISEF · 2023
A Novel siRNA-Based Drug for the Treatment of Hepatocellular Carcinoma
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects